Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

Movement Disorders

Volumn 21, Issue 7, 2006, Pages 964-969

  Ton, Thanh G ^a   Heckbert, Susan R ^a   Longstreth Jr , W T ^a   Rossing, Mary Anne ^a,b   Kukull, Walter A ^a   Franklin, Gary M ^a   Swanson, Phillip D ^a   Smith Weller, Terri ^a   Checkoway, Harvey ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Aspirin; Inflammation; Nonsteroidal anti inflammatory drugs; NSAIDs; Parkinson's disease

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; ETODOLAC; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOROLAC; MECLOFENAMIC ACID; MEFENAMIC ACID; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; ROFECOXIB; SULINDAC; TOLMETIN;

ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTHRITIS; ARTICLE; AUTOMATION; CIGARETTE SMOKING; CONTROLLED STUDY; DATA BASE; DRUG EXPOSURE; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HEART DISEASE; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; INDIVIDUALITY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROPROTECTION; PARKINSON DISEASE; PATIENT INFORMATION; PATIENT PARTICIPATION; PATIENT SELECTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZATION; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; TREATMENT INDICATION; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; ODDS RATIO; OXIDATIVE STRESS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; RISK; WASHINGTON;

EID: 33746894717     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20856     Document Type: Article

References (19)

1. Liu B, Gao HM, Hong JS. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect 2003; 111:1065-1073.
2. Jenner P, Olanow CW. Understanding cell death in Parkinson's disease. Ann Neurol 1998;44(Suppl. 1):S72-S84.
3. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 1999;96:9879-9884.
4. Rothwell NJ, Strijbos PJ. Cytokines in neurodegeneration and repair. Int J Dev Neurosci 1995;13:179-185.
5. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995;21:195-218.
6. Golbe LI. Alpha-synuclein and Parkinson's disease. Mov Disord 1999;14:6-9.
7. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889-909.
8. Casper D, Yaparpalvi U, Rempel N, Werner P. Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci Lett 2000;289:201-204.
9. Sairam K, Saravanan KS, Banerjee R, Mohanakumar KP. Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Brain Res 2003;966: 245-252.
10. Aubin N, Curet O, Deffois A, Carter C. Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 1998;71:1635-1642.
11. Bilodeau JF, Wang M, Chung FL, Castonguay A. Effects of nonsteroidal antiinflammatory drugs on oxidative pathways in A/J mice. Free Radic Biol Med 1995;18:47-54.
12. Kaufmann W, Andreasson K, Isakson P, Worley P. Cyclooxygenases and the central nervous system. Prostaglandins 1997;54:601-624.
13. Saini T, Bagchi M, Bagchi D, Jaeger S, Hosoyama S, Stuhs SJ. Protective ability of acetylsalicylic acid (aspirin) to scavenge radiation induced free radicals in J774A.1 macrophage cells. Res Commun Mol Pathol Pharmacol 1998;101:259-268.
14. Chen H, Zhang SM, Hernan MA, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 2003;60:1059-1064.
15. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT, Jr., Swanson PD. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002;155:732-738.
16. Wickersham RM, Novak KK, eds. Drug Facts and Comparisons. St. Louis, MO: Wolters Kluwer Health; 2005.
17. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-625.
18. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AH. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem 1994;63:1987-1990.
19. Saunders KW SA, Von Korff M. Group Health Cooperative of Puget Sound. In: Strom B, editor. Pharmacoepidemiology, 2nd ed. New York: John Wiley and Sons, 1994:171-185.